Target intelligence / Profile preview

SYNCRIP pseudogene 1 (SYNCRIPP1)

Target
SYNCRIPP1
Molecular classification
Pseudogene, Transcribed pseudogene, Non-coding RNA
01

Overview

**SYNCRIP pseudogene 1 (SYNCRIPP1)** is a human pseudogene, classified as a transcribed pseudogene. Pseudogenes are genomic sequences similar to known genes but are non-functional due to disruptive mutations, often acquired through gene duplication or retrotransposition[1][2][3][6]. While some pseudogenes can be transcribed and have regulatory effects as non-coding RNAs[6], there is currently no evidence that SYNCRIPP1 acts as a protein-coding gene or exerts a functional regulatory role, nor is it considered a therapeutic target. No links to specific disease relevance or drug interactions have been documented. The canonical gene SYNCRIP is a functioning protein-coding gene involved in RNA binding, but SYNCRIPP1 is not known to encode protein or serve as a druggable target. **Key points:** - SYNCRIPP1 is not a drug target, receptor, enzyme, or similar molecule, but a non-coding pseudogene[1][2][3][6]. - No evidence exists for involvement in human disease or drug interaction. - If a target is required for therapeutic purposes, canonical "SYNCRIP" (not SYNCRIPP1) should be considered, but these are distinct entities. This entry is not a therapeutic target and its use as such would be incorrect.

Other names
synaptotagmin binding cytoplasmic RNA interacting protein pseudogeneSYNCRIPP1
02

Biological functions

Other (pseudogenes generally do not encode proteins and most have no direct biological function; few pseudogenes may play regulatory roles if transcribed)

Beyond the preview

Go deeper on SYNCRIP pseudogene 1 (SYNCRIPP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SYNCRIP pseudogene 1 (SYNCRIPP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call